4NCT image
Deposition Date 2013-10-25
Release Date 2015-04-01
Last Version Date 2024-11-20
Entry Detail
PDB ID:
4NCT
Title:
Human DYRK1A in complex with PKC412
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Dual specificity tyrosine-phosphorylation-regulated kinase 1A
Gene (Uniprot):DYRK1A
Chain IDs:A, B, D
Chain Length:368
Number of Molecules:3
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Dual specificity tyrosine-phosphorylation-regulated kinase 1A
Gene (Uniprot):DYRK1A
Chain IDs:C
Chain Length:368
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR A TYR O-PHOSPHOTYROSINE
SEP C SER PHOSPHOSERINE
Ligand Molecules
Primary Citation
The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A-PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD(HCD) cysteine.
Acta Crystallogr.,Sect.D 71 1207 1215 (2015)
PMID: 25945585 DOI: 10.1107/S1399004715005106

Abstact

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase associated with neuronal development and brain physiology. The DYRK kinases are very unusual with respect to the sequence of the catalytic loop, in which the otherwise highly conserved arginine of the HRD motif is replaced by a cysteine. This replacement, along with the proximity of a potential disulfide-bridge partner from the activation segment, implies a potential for redox control of DYRK family activities. Here, the crystal structure of DYRK1A bound to PKC412 is reported, showing the formation of the disulfide bridge and associated conformational changes of the activation loop. The DYRK kinases represent emerging drug targets for several neurological diseases as well as cancer. The observation of distinct activation states may impact strategies for drug targeting. In addition, the characterization of PKC412 binding offers new insights for DYRK inhibitor discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures